Robert Clarke is the founder of Kinaset Therapeutics. Kinaset Therapeutics has raised $150M in total funding. Latest round: Series B. Based in Medfield, MA.
Robert Clarke, PhD, is a co-founder and Chief Executive Officer of Kinaset Therapeutics since its inception in 2020. Under his leadership, Kinaset has advanced its lead best-in-class inhaled pan JAK program to Phase 2 for severe asthma. The company has raised over $150M through two rounds of private financing. Prior to Kinaset, he was CEO at Pulmatrix Inc. from 2012 to 2019, taking the company public in 2015. He began his industry career at Alkermes.
Full founder directory · Investor directory · Company funding database · Fundraising library